(NASDAQ: INBS) Intelligent Bio Solutions's forecast annual revenue growth rate of 65.09% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Intelligent Bio Solutions's revenue in 2024 is $2,880,108.On average, 1 Wall Street analysts forecast INBS's revenue for 2024 to be $8,913,324, with the lowest INBS revenue forecast at $8,913,324, and the highest INBS revenue forecast at $8,913,324. On average, 1 Wall Street analysts forecast INBS's revenue for 2025 to be $15,549,992, with the lowest INBS revenue forecast at $15,549,992, and the highest INBS revenue forecast at $15,549,992.
In 2026, INBS is forecast to generate $26,117,114 in revenue, with the lowest revenue forecast at $26,117,114 and the highest revenue forecast at $26,117,114.